Menu Back to Canadian-Pharmacovigilance-and-Risk-Management-Strategies-Conference


DIA’s Canadian Pharmacovigilance and Risk Management Strategies Conference is the premier place to hear from expert pharmaceutical, biotechnology, and regulatory personnel. The latest updates in pharmacovigilance, risk management, and drug safety will be presented from both a global and a tailored Canadian perspective.

Great learning opportunity with Health Canada speakers to get the latest updates and be able to directly ask them questions.
-Previous Attendee

Very informative. I liked how we had the opportunity to discuss issues/topics with Health Canada.
-Previous Attendee


  • Risk management for opioids
  • Cybersecurity and implications for pharmacovigilance
  • Round table with Inspector
  • Canada vigilance update by Health Canada

Travel Once, Learn Twice!
This year the Canadian Pharmacovigilance and Risk Management Strategies Conference will be co-located with the DIA Annual Canadian Meeting. Maximize your education and time by attending both! Save* $150 when you register for both!
*You must register for both events at the same time. 

Who should attend?

Professionals involved in:
  • Regulatory
  • Policy
  • Clinical trial disclosure policies and compliance
  • Clinical operations or clinical research
  • Medical writing and communications
  • Legal
  • Market access
  • Learning objectives

    At the conclusion of this conference, participants should be able to:

    • Describe the current Canadian regulatory framework for pharmacovigilance
    • Identify current pharmacovigilance issues facing Marketing Authorization Holders in Canada
    • Describe the challenges of cybersecurity and strategies to cybersecurity implementation

    Program Committee

    • Rita  Cassola, RPh
      Rita Cassola, RPh Executive Director PV
      Certus PV Services Inc, Canada
    • Marcia  Bailey, BSN, MHS, RN
      Marcia Bailey, BSN, MHS, RN Senior Manager, Pharmacovigilance
      Sierra Oncology , Canada
    • Colin  D'Cunha, MD, MHS, FRCPC
      Colin D'Cunha, MD, MHS, FRCPC Director, Global Medical Affairs
      Apotex Inc., Canada
    • Melissa  Hunt, MSc
      Melissa Hunt, MSc Director
      Health Canada, Canada
    • Marc  Poitras, PhD, MBA
      Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
      Health Canada, Canada
    Load More

    Contact us

    Registration Questions?

    Send Email

    Co-located Meeting

    Annual Canadian Meeting
    *Save $150 when you register for both at the same time!

    Digital Learning Catalog

    DIA Learning: eLearning Soultions